Vantage Investment Advisors’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-3,000
| Closed | -$7K | – | 770 |
|
|
2018
Q1 | $7K | Hold |
3,000
| – | – | ﹤0.01% | 614 |
|
|
2017
Q4 | $12K | Hold |
3,000
| – | – | ﹤0.01% | 539 |
|
|
2017
Q3 | $8K | Hold |
3,000
| – | – | ﹤0.01% | 591 |
|
|
2017
Q2 | $8K | Hold |
3,000
| – | – | ﹤0.01% | 586 |
|
|
2017
Q1 | $6K | Hold |
3,000
| – | – | ﹤0.01% | 609 |
|
|
2016
Q4 | $3K | Hold |
3,000
| – | – | ﹤0.01% | 672 |
|
|
2016
Q3 | $3K | Hold |
3,000
| – | – | ﹤0.01% | 650 |
|
|
2016
Q2 | $2K | Hold |
3,000
| – | – | ﹤0.01% | 720 |
|
|
2016
Q1 | $4K | Hold |
3,000
| – | – | ﹤0.01% | 641 |
|
|
2015
Q4 | $7K | Hold |
3,000
| – | – | ﹤0.01% | 553 |
|
|
2015
Q3 | $9K | Hold |
3,000
| – | – | 0.01% | 512 |
|
|
2015
Q2 | $12K | Sell |
3,000
-3,000
| -50% | -$12K | 0.01% | 442 |
|
|
2015
Q1 | $26K | Buy |
6,000
+3,000
| +100% | +$13K | 0.01% | 443 |
|
|
2014
Q4 | $9K | Hold |
3,000
| – | – | 0.01% | 515 |
|
|
2014
Q3 | $10K | Hold |
3,000
| – | – | 0.01% | 472 |
|
|
2014
Q2 | $8K | Hold |
3,000
| – | – | ﹤0.01% | 497 |
|
|
2014
Q1 | $7K | Hold |
3,000
| – | – | ﹤0.01% | 474 |
|
|
2013
Q4 | $6K | Buy |
+3,000
| New | +$6K | ﹤0.01% | 472 |
|